These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26671852)

  • 21. Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.
    Pettinato C; Monari F; Nanni C; Allegri V; Marcatili S; Civollani S; Cima S; Spezi E; Mazzarotto R; Fanti S
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):509-14. PubMed ID: 23358403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging.
    Stillebroer AB; Zegers CM; Boerman OC; Oosterwijk E; Mulders PF; O'Donoghue JA; Visser EP; Oyen WJ
    J Nucl Med; 2012 Jan; 53(1):82-9. PubMed ID: 22159179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetry of
    Sarnelli A; Belli ML; Di Iorio V; Mezzenga E; Celli M; Severi S; Tardelli E; Nicolini S; Oboldi D; Uccelli L; Cittanti C; Monti M; Ferrari M; Paganelli G
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30754620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial.
    Liu B; Kuang A; Huang R; Zhao Z; Zeng Y; Wang J; Tian R
    J Nucl Med; 2010 Apr; 51(4):618-23. PubMed ID: 20237029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
    Pahlka RB; Sonnad JR
    Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma.
    Hermanská J; Kárný M; Zimák J; Jirsa L; Sámal M; Vlcek P
    J Nucl Med; 2001 Jul; 42(7):1084-90. PubMed ID: 11438632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioiodine uptake in thyroid remnants during therapy after tracer dosimetry.
    Yeung HW; Humm JL; Larson SM
    J Nucl Med; 2000 Jun; 41(6):1082-5. PubMed ID: 10855639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation Safety Precautions in (131)I Therapy of Graves' Disease Based on Actual Biokinetic Measurements.
    Liu B; Tian R; Peng W; He Y; Huang R; Kuang A
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2934-41. PubMed ID: 26046966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
    Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
    J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Dosimetry-based model for estimation.
    Jentzen W; Moldovan AS; Ruhlmann M; Görges R; Bockisch A; Rosenbaum-Krumme S
    Nuklearmedizin; 2015; 54(3):137-43. PubMed ID: 25987357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation dose to the upper spine from therapeutic administrations of iodine-131-sodium iodide.
    Stabin MG
    J Nucl Med; 1993 Apr; 34(4):695-6. PubMed ID: 8455090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies.
    Bartlett ML; Webb M; Durrant S; Morton AJ; Allison R; Macfarlane DJ
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1470-7. PubMed ID: 12397466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of blood and bone marrow doses of thyroid carcinoma patients treated with
    Albornoz-Castañeda F; Díaz-Londoño G; García-Arencibia M; Sirandoni-Riquelme G
    J Radiol Prot; 2018 Dec; 38(4):1359-1370. PubMed ID: 30226212
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of radioiodine therapy on pulmonary alveolar-capillary membrane integrity.
    Samuel AM; Unnikrishnan TP; Baghel NS; Rajashekharrao B
    J Nucl Med; 1995 May; 36(5):783-7. PubMed ID: 7738648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma.
    Dauer LT; St Germain J; Williamson MJ; Zanzonico P; Modak S; Cheung NK; Divgi C
    Health Phys; 2007 Jan; 92(1):33-9. PubMed ID: 17164597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 131I Biokinetics and cytogenetic dose estimates in ablation treatment of thyroid carcinoma.
    Nascimento AC; Lipsztein JL; Corbo R; Rebelo AM
    Health Phys; 2010 Oct; 99(4):457-63. PubMed ID: 20838086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetry in the therapy of metastatic differentiated thyroid cancer administering high 131I activity: the experience of Busto Arsizio Hospital (Italy).
    Bianchi L; Baroli A; Lomuscio G; Pedrazzini L; Pepe A; Pozzi L; Chiesa C
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):515-21. PubMed ID: 23358404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism.
    Stabin MG; Watson EE; Marcus CS; Salk RD
    J Nucl Med; 1991 May; 32(5):808-13. PubMed ID: 2022987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.